AfroCentric Investment Corp Ltd 2015 IR
The report outlines AfroCentric Group's financial and operational performance for the 2015 fiscal year, highlighting a 7% increase in revenue to exceed R2 billion and a 13.4% rise in profit before tax to R279 million. Key strategic developments included Sanlam Limited acquiring a 28.7% stake in AfroCentric Healthcare Assets and the acquisition of Pharmacy Direct to expand into the healthcare supply value chain. Medscheme, the Group's largest subsidiary, was appointed as the administrator and managed care provider to the SA Police Medical Scheme (Polmed). The Group also maintained its Level 2 B-BBEE status for the third consecutive year and continued its commitment to transformation and community development.
Company: AfroCentric Investment Corp Ltd
Sector: Financials
Country: South Africa
Year: 2015
Type: IR
Pages: 100
AfroCentric Investment Corp Ltd
The report outlines AfroCentric Group's financial and operational performance for the 2015 fiscal year, highlighting a 7% increase in revenue to exceed R2 billion and a 13.4% rise in profit before tax to R279 million. Key strategic developments included Sanlam Limited acquiring a 28.7% stake in AfroCentric Healthcare Assets and the acquisition of Pharmacy Direct to expand into the healthcare supply value chain. Medscheme, the Group's largest subsidiary, was appointed as the administrator and managed care provider to the SA Police Medical Scheme (Polmed). The Group also maintained its Level 2 B-BBEE status for the third consecutive year and continued its commitment to transformation and community development.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jul 1, 2014 - Jun 30, 2015
Fiscal Year
2015
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees